BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38760516)

  • 1. MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer's Disease by modulating Hippo-Wnt signaling crosstalk.
    Sahu MR; Ahmad MH; Mondal AC
    Apoptosis; 2024 May; ():. PubMed ID: 38760516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload.
    Triastuti E; Nugroho AB; Zi M; Prehar S; Kohar YS; Bui TA; Stafford N; Cartwright EJ; Abraham S; Oceandy D
    Br J Pharmacol; 2019 Oct; 176(20):3956-3971. PubMed ID: 31328787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice.
    Faizah Z; Amanda B; Ashari FY; Triastuti E; Oxtoby R; Rahaju AS; Aziz MA; Lusida MI; Oceandy D
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32987643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XMU-MP-1 protects heart from ischemia/reperfusion injury in mice through modulating Mst1/AMPK pathway.
    Liu Y; Chu G; Shen W; Zhang Y; Xu W; Yu Y
    Eur J Pharmacol; 2022 Mar; 919():174801. PubMed ID: 35123978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration.
    Fan F; He Z; Kong LL; Chen Q; Yuan Q; Zhang S; Ye J; Liu H; Sun X; Geng J; Yuan L; Hong L; Xiao C; Zhang W; Sun X; Li Y; Wang P; Huang L; Wu X; Ji Z; Wu Q; Xia NS; Gray NS; Chen L; Yun CH; Deng X; Zhou D
    Sci Transl Med; 2016 Aug; 8(352):352ra108. PubMed ID: 27535619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway.
    Zhang N; Ye T; Lu X; Li ZH; Li L
    Chin J Integr Med; 2023 Nov; 29(11):998-1006. PubMed ID: 37661231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with XMU-MP-1 erases hyperglycaemic memory in hearts of diabetic mice.
    Zhang Z; Si YF; Hu W; Yan P; Yu Y
    Biochem Pharmacol; 2021 Jun; 188():114574. PubMed ID: 33887258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of Hippo Pathway Proteins in Thrombin-Stimulated Platelets and Regutates Platelets Activation in Vitro].
    Qiao CC; Sun P; Yuan X; Su N; Jiang P; Lin FZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1143-1149. PubMed ID: 37551490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XMU-MP-1 attenuates osteoarthritis via inhibiting cartilage degradation and chondrocyte apoptosis.
    Hao X; Zhao J; Jia L; He T; Wang H; Fan J; Yang Y; Su F; Lu Q; Zheng C; Yang L; Jie Q
    Front Bioeng Biotechnol; 2022; 10():998077. PubMed ID: 36199358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer's disease.
    Wang H; Shang Y; Wang E; Xu X; Zhang Q; Qian C; Yang Z; Wu S; Zhang T
    Prog Neurobiol; 2022 Jul; 214():102280. PubMed ID: 35525373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways.
    Salem MA; Budzyńska B; Kowalczyk J; El Sayed NS; Mansour SM
    Toxicol Appl Pharmacol; 2021 Oct; 429():115697. PubMed ID: 34428446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mst1/2 Kinases Inhibitor, XMU-MP-1, Attenuates Angiotensin II-Induced Ascending Aortic Expansion in Hypercholesterolemic Mice.
    Okuyama M; Jiang W; Yang L; Subramanian V
    Circ Rep; 2021 Apr; 3(5):259-266. PubMed ID: 34007939
    [No Abstract]   [Full Text] [Related]  

  • 13. MST1/2 inhibitor XMU-MP-1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system.
    Zhou X; Wang H; Li D; Song N; Yang F; Xu W
    J Cell Mol Med; 2022 Mar; 26(5):1621-1628. PubMed ID: 35088536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity.
    Mitchell E; Mellor CEL; Purba TS
    Cell Div; 2020; 15():11. PubMed ID: 32973917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grape Seed Proanthocyanidin Extract Ameliorates Streptozotocin-induced Cognitive and Synaptic Plasticity Deficits by Inhibiting Oxidative Stress and Preserving AKT and ERK Activities.
    Gao WL; Li XH; Dun XP; Jing XK; Yang K; Li YK
    Curr Med Sci; 2020 Jun; 40(3):434-443. PubMed ID: 32681248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.
    Hasan N; Zameer S; Najmi AK; Parvez S; Akhtar M
    Neurotox Res; 2022 Apr; 40(2):432-448. PubMed ID: 35192144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1.
    Xu QQ; Su ZR; Hu Z; Yang W; Xian YF; Lin ZX
    Phytomedicine; 2022 Nov; 106():154441. PubMed ID: 36108371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
    Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions.
    Kang BW; Kim F; Cho JY; Kim S; Rhee J; Choung JJ
    Alzheimers Res Ther; 2022 Jul; 14(1):92. PubMed ID: 35804462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
    Yan D; Li G; Zhang Y; Liu Y
    Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.